CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Turtle et al.
Papers
The Journal of Clinical Investigation
April 2016
Authors and Affiliates
Cameron J. Turtle,1,2 Laïla-Aïcha Hanafi,1 Carolina Berger,1,2 Theodore A. Gooley,1 Sindhu Cherian,3 Michael Hudecek,1 Daniel Sommermeyer,1Katherine Melville,1 Barbara Pender,1 Tanya M. Budiarto,1 Emily Robinson,1 Natalia N. Steevens,1 Colette Chaney,1 Lorinda Soma,3 Xueyan Chen,3 Cecilia Yeung,3,4 Brent Wood,3,4 Daniel Li,5 Jianhong Cao,1 Shelly Heimfeld,1 Michael C. Jensen,1,6 Stanley R. Riddell,1,2,7 and David G. Maloney1,2
1 Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA. 2 Department of Medicine, 3 Department of Laboratory Medicine, and 4 Department of Pathology, University of Washington, Seattle, Washington, USA. 5 Juno Therapeutics, Seattle, Washington, USA. 6 Seattle Children’s Research Institute, Seattle, Washington, USA. 7 Institute for Advanced Study, Technical University of Munich, Munich, Germany